{
    "eid": "2-s2.0-85133655166",
    "title": "Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Adverse-risk acute myeloid leukemia",
        "Consolidation therapy",
        "High-dose cytarabine",
        "Intermediate-dose cytarabine",
        "Intermediate-risk acute myeloid leukemia"
    ],
    "authors": [
        "Chantiya Chanswangphuwana",
        "Chantana Polprasert",
        "Weerapat Owattanapanich",
        "Smith Kungwankiattichai",
        "Ekarat Rattarittamrong",
        "Thanawat Rattanathammethee",
        "Wasithep Limvorapitak",
        "Supawee Saengboon",
        "Pimjai Niparuck",
        "Teeraya Puavilai",
        "Jakrawadee Julamanee",
        "Pirun Saelue",
        "Chinadol Wanitpongpun",
        "Chajchawan Nakhakes",
        "Kannadit Prayongratana",
        "Chantrapa Sriswasdi"
    ],
    "citedby-count": 1,
    "ref-count": 23,
    "ref-list": [
        "Acute myeloid leukemia",
        "Acute myeloid leukaemia and related precursor neoplasm",
        "Intensive postremission chemotherapy in adults with acute myeloid leukemia",
        "Sense and nonsense of high-dose cytarabine for acute myeloid leukemia",
        "High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial",
        "A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study",
        "Randomized trial of intermediate-dose cytarabine in induction and consolidation therapy in adults with acute myeloid leukemia",
        "Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222",
        "Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study",
        "Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines",
        "Comparison of mitoxantrone in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for young non-APL acute myeloid leukemia patients with favorable and intermediate cytogenetics",
        "Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial",
        "Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis",
        "A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia",
        "Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in acute myeloid leukemia patients",
        "Cytarabine dose of 36 g/m\u00b2 compared with 12 g/m\u00b2 within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study",
        "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel",
        "High risk of relapse with intermediate dose cytarabine for consolidation in young favourable-risk acute myeloid leukaemia patients following induction with 7+3: a retrospective multicentre analysis and critical review of the literature",
        "Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype",
        "High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis",
        "Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis",
        "Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america",
        "Standard-intensity induction and intermediate/high-dose cytarabine consolidation can improve survival for elderly patients with newly diagnosed acute myeloid leukemia: a retrospective cohort study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60012521",
            "affilname": "Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012521",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}